Literature DB >> 29852263

Design, synthesis, and anti-inflammatory activity of caffeoyl salicylate analogs as NO production inhibitors.

Pan Yu1, Chao-Jie Xia1, Dong-Dong Li1, Jun-Jun Ni1, Lin-Guo Zhao2, Gang Ding3, Zhen-Zhong Wang3, Wei Xiao4.   

Abstract

Chlorogenic acid (CGA) has been reported to exhibit potent anti-inflammatory activity. However, the development of anti-inflammatory agent based on CGA has not been investigated. In this paper, a series of caffeoyl salicylate compounds derived from CGA were designed, synthesized, and evaluated by LPS-induced nitric oxide synthase inhibition and QRT-PCR technique. Most compounds showed modest activity to inhibit production of nitric oxide (NO) in RAW 264.7 cells induced by lipopolysaccharides (LPS). Among these compounds, QRT-PCR and western blotting results indicated that compounds 6b, 6c, 6f, 6g and D104 that possess 5-member ring or 6-member ring caused a significant inhibition against expression of the iNOS2 in LPS-induced macrophages. In addition, cytotoxic assay displayed most derivatives have good safety in vitro. This new promising scaffold could be further exploited for the development of anti-inflammatory agent in the future.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Caffeoyl salicylate analogs; Chlorogenic acid; Nitric oxide synthase

Mesh:

Substances:

Year:  2018        PMID: 29852263     DOI: 10.1016/j.fitote.2018.05.029

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  2 in total

1.  Discovery of 7,9-Disulfatetrahydroberberine as Novel Lipid-Lowering Agents.

Authors:  Dong-Dong Li; Pan Yu; Zhen-Zhong Wang; Wei Xiao; Xin-Hu Zhou; Lin-Guo Zhao
Journal:  ACS Omega       Date:  2020-11-25

2.  Design, Synthesis, and Antitumor Evaluation of Novel Mono-Carbonyl Curcumin Analogs in Hepatocellular Carcinoma Cell.

Authors:  Pan Yu; Weiya Cao; Linguo Zhao; Qing Han; Shilong Yang; Kepeng Yang; Xiaolei Pan; Qianyun Wang; Yuan Wang
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.